Home

Dividend of Senores Pharmaceuticals Ltd

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

Dividend Payout (-)

-

Ex-Dividend Date: NA

Key Highlights

  • The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 553.7 as of 06 Jan 15:30 .

swot
swot

Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities.

Dividend Payout Over Time

No data available

Overview of Dividend

  • <h2><strong>Types of Dividend</strong></h2><br> <h3>Special Dividend</h3> <p>A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.</p> <br> <h3>Preferred Dividend</h3> <p>A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.</p> <br> <h3>Interim Dividend</h3> <p>Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.</p> <br> <h3>Final Dividend</h3> <p>A final dividend is issued after the year's accounts have been compiled.
  • Aside from this, the following list highlights the most prevalent sorts of dividends:</p> <br>.

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Dividend Yield Comparison With Top Peers

* All values are in %

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

Share Price

₹ 553.7

-19.30 (-3.37%)

stock direction

Last updated on: Jan 06, 2025

Company Fundamentals for Senores Pharmaceuticals Ltd

Dividend Payout Over Time

No data available

Net Profit Vs Dividend Per Share

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Senores Pharmaceuticals Ltd

Historical Market Cap of Senores Pharmaceuticals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Senores Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Senores Pharmaceuticals Ltd News Hub

Senores Pharmaceuticals IPO subscribed 93.41 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a

Read more

2024-12-24 00:00:00

Senores Pharmaceuticals IPO ends with 93.69x subscription

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,95,96,646 shares as a

Read more

2024-12-26 00:00:00

Senores Pharmaceuticals IPO subscribed 1.78 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 1,51,51,550 shares as ag

Read more

2024-12-20 00:00:00

Senores Pharmaceuticals makes strong debut

The scrip was listed at Rs 593.70, exhibiting a premium of 51.84% to the issue price. So far, the st

Read more

2024-12-30 00:00:00

About Senores Pharmaceuticals Ltd

  • Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
  • Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
  • The Regulated Markets business is focused on Regulated Markets of US and Canada.
  • The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions